Elisabeth Kjellén

Lund University — Sweden

Medicine · Health Sciences

32h-index4.2kcitations165works0.72yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(33), Advanced Radiotherapy Techniques(30), Prostate Cancer Diagnosis and Treatment(19), Lung Cancer Treatments and Mutations(16), Prostate Cancer Treatment and Research(15)

Publications164 total

Routinely collected health data on 10-year genitourinary and gastrointestinal morbidity after ultra-hypofractionated versus conventionally fractionated radiotherapy for localised prostate cancer in the randomised, non-inferiority, phase 3 trial HYPO-RT-PC
Radiotherapy and Oncology·2025· 1 citedOpen Access
Internal mammary node irradiation in early breast cancer – target coverage and implications on dose to organs at risk
Acta Oncologica·2025Open Access
Automated segmentation of target volumes in breast cancer radiotherapy, impact on target size and dose to organs at risk
Clinical and Translational Radiation Oncology·2025· 1 citedOpen Access
4981 Ultra-hypofractionated radiotherapy for localised prostate cancer: 10-year outcomes of the HYPO-RT-PC phase 3 trial (ISRCTN45905321)
Radiotherapy and Oncology·2025· 2 cited
9 Prostate-specific antigen bounce after prostate ultra-hypofractionation: associations with 5-year outcomes in the phase 3 trial HYPO-RT-PC
Radiotherapy and Oncology·2025
11: Register data on long-term morbidity after prostate ultra-hypofractionation in the HYPO-RT-PC trial
Radiotherapy and Oncology·2024
Ultrahypofractionated Radiation Therapy for Prostate Cancer Including Seminal Vesicles in the Target Volume: A Treatment-planning Study Based on the HYPO-RT-PC Fractionation Schedule
Advances in Radiation Oncology·2024· 1 citedOpen Access
Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer
Technical Innovations & Patient Support in Radiation Oncology·2023· 3 citedOpen Access
A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and 68Ga-PSMA-PET for biochemical relapse after radical prostatectomy – The PROPER 1 trial
Clinical and Translational Radiation Oncology·2022· 7 citedOpen Access
Primary tumor volume and prognosis for patients with p16-positive and p16-negative oropharyngeal squamous cell carcinoma treated with radiation therapy
Radiation Oncology·2022· 15 citedOpen Access
Results from a prospective, randomised study on (accelerated) preoperative versus (conventional) postoperative radiotherapy in treatment of patients with resectable squamous cell carcinoma of the oral cavity – The ARTSCAN 2 study
Radiotherapy and Oncology·2021· 7 citedOpen Access
Adaptive sequential plan-on-plan optimization during prostate-specific antigen response guided radiotherapy of recurrent prostate cancer
Physics and Imaging in Radiation Oncology·2021· 3 citedOpen Access
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
The Lancet Oncology·2021· 151 cited
COVID-19 Concerns Among Old Age Psychiatric In- and Out-Patients and the Employees Caring for Them, a Preliminary Study
Frontiers in Psychiatry·2020· 6 citedOpen Access
Long-Term Risk of Hip Complications After Radiation Therapy for Prostate Cancer: A Dose-Response Study
Advances in Radiation Oncology·2020· 16 citedOpen Access
PSA decay during salvage radiotherapy for prostate cancer as a predictor of disease outcome – 5 year follow-up of a prospective observational study
Clinical and Translational Radiation Oncology·2020· 6 citedOpen Access
No Increased Cardiac Mortality or Morbidity of Radiation Therapy in Breast Cancer Patients After Breast-Conserving Surgery: 20-Year Follow-up of the Randomized SweBCGRT Trial
International Journal of Radiation Oncology*Biology*Physics·2020· 31 cited
Altered fractionation diminishes importance of tumor volume in oropharyngeal cancer: Subgroup analysis of ARTSCAN‐trial
Head & Neck·2020· 11 citedOpen Access
Erectile Dysfunction and Absorbed Dose to Penile Base Structures in a Randomized Trial Comparing Ultrahypofractionated and Conventionally Fractionated Radiation Therapy for Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics·2020· 30 cited
Substantial intrinsic variability in chemoradiosensitivity of newly established anaplastic thyroid cancer cell-lines
Acta Oto-Laryngologica·2020Open Access
page 1 of 9Next →

Frequent Co-authors

Per Nilsson(21), Adalsteinn Gunnlaugsson(10), Björn Zackrisson(10), Eva Brun(7), Anders Widmark(6), Lars Franzén(6), Johan Wennerberg(6), Peter Wahlberg(6), Camilla Thellenberg‐Karlsson(5), Magnus Lagerlund(5), Johan Wennerberg(5), Anders Johnsson(5), L. Beckman(4), Morten Høyer(4), Jon Kindblom(4), Claes Ginman(4), Bengt Johansson(4), M. Seke(4), Göran Laurell(4), Fredrika Killander(4)